The PTAC demobilized on Sunday, November 7, 2021. Hospitals should utilize their existing transfer methods. 

Updates:

Therapeutics Ordering Timeline: Therapeutics Providers must place their mAb order each week by Thursday at 5:00 PM Central Time. Allocation considerations are based on a weekly cycle.  A new allocation cycle begins each Friday. For your request to be considered for the upcoming cycle (Cycle 14, December 10th – December 16th), your order must be placed in VAOS no later than Thursday, December 9th by 5:00 PM, Central Time. Any requests received after Thursday at 5:00 PM will be considered for the following allocation cycle (December 17th – December 23rd).  Please note that if you are not allotted any therapeutics in a given allocation cycle, you must submit another order request the following cycle; requests are not carried over from week to week. 

Therapeutics Newsletters: The 8th edition of the COVID-19 Therapeutics Provider Weekly News Digest is available. The newsletter will include important COVID-19 therapeutics-related news and updates. If you would like to add a member of your facility to the Therapeutics Newsletter mailing list, please contact therapeutics@dshs.texas.gov.

Federal COVID-19 Response: Therapeutics 210 Webinars: The U.S. Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response (ASPR) is transitioning from the Monoclonal Antibodies (mAbs) 101 webinar to the Federal COVID-19 Response: Therapeutics 210 webinar on Fridays, from 11:00 AM – 12:00 PM, Central Time. 

This webinar will take a deep dive into COVID-19 therapies, cover new developments including Oral Antivirals, update the implementation and COVID-19 treatment guidance, best practices for administration, clinical and operational data, provider and patient resources, the distribution process, and more. The content for the webinar will be similar each week while staying current on evolving therapeutics topics. 

Please click here to join the Federal COVID-19 Response: Therapeutics 210 Webinar
Webinar ID: 161 753 6991
Passcode: 113212

DSHS added a module to the Vaccine Allocation and Ordering System (VAOS) to allow providers to put in their mAb requests through VAOS. To view the training on the “Therapeutics Order Request in VAOS”, click on the link below.
Ordering Monoclonal Antibodies in VAOS
Provider Webinar Video (Vimeo, released 9/20/2021)
Provider Webinar Slides (PDF, released 9/20/2021)

Reminder: The State of Texas Assistance Request (STAR) process should NOT be used for requesting therapeutics. All STARs submitted for therapeutics will be marked not filled.  If you have further questions regarding the new process, email therapeutics@dshs.texas.gov.

CLICKABLE LINK

COVID-19 Therapeutics Allocation Request Job Aid – DSHS

Coronavirus Disease 2019 (COVID-19) Treatment Guidelines – NIH

Updated COVID-19 Treatment Guidelines Panel’s Statement on the Prioritization of Anti-SARS-CoV-2 Monoclonal Antibodies for the Treatment or Prevention of SARS-CoV-2 Infection When There Are Logistical or Supply Constraints

DSHS Clarification on mAb shipments update 09-15-2021 – DSHS

COVID-19 Monoclonal Antibody (mAb)Therapeutics Provider Webinar 09-20-2021 – DSHS

The COVID-19 Antibody Infusion Center – McKinney opened in early September and has begun accepting patients. Local partners for this infusion center include Collin County, NCTTRAC, Baylor Scott & White, and Collin College. This site will provide Regeneron’s Monoclonal Antibodies to treat outpatient patients of COVID-19 who have a referral from a doctor. COVID-19 antibody treatment can prevent a patient’s condition from worsening and requiring hospital care. These infusion treatments are funded by the state and have no cost to the patient or the referring provider.  

Key Points

• The Infusion Center is located at Collin College at the McKinney Campus Conference Center, 2400 Community Avenue, McKinney, on the corner of Community Ave. & Taylor Burk. The patient entrance is located on the North/East side of the conference building. 
• Walk-ins are accepted; if the center is unable to see walk-ins due to volume, the center will schedule the walk-ins for an appointment the next day.
• Walk-ins must provide documentation of a recent positive COVID test (within 10 days).
• This is a state-funded operation – there is no cost to the patient or referring provider. 
• The Regional Infusion Center utilizes the monoclonal antibody treatment Regeneron – COV (Casirivimab plus Imdevimab). 
• Operating Hours: 7:00 AM – 6:00 PM, 7 days a week.
• Call the Infusion Center’s main number at 972-548-6645 to address referral questions.

Below you will find step-by-step instructions for both referring physicians and patients.

I am a Patient – How Do I get access to the Regional Infusion Center – McKinney?

• Contact your local physician to see if you are eligible for the Regeneron infusion.
• You can be referred for infusion by a primary care physician, freestanding emergency department, or hospital.
• If your physician determines that you are eligible, they need to fill out and submit the Collin College Outpatient Monoclonal Antibody Infusion Protocol Form, provide documentation of your positive COVID test and history & physical examination, or a doctor’s visit document explaining how you meet the criteria. 
• Once your physician submits your referral form, you will receive a call from the Infusion Center to schedule an appointment.

I am a Physician – How Do I Refer a Patient for Infusion?

• To order, send the following documentation via email: The completed Collin College Outpatient Monoclonal Antibody Infusion Protocol Form (located below in the “CLICKABLE LINKS” section), positive COVID test documentation, history & physical examination, or your visit document explaining how the patient meets criteria. 
• To order, send the documents mentioned above:
  • By Email: Infusion@collin.edu

LOOKING FOR MORE?

Please see the “CLICKABLE LINKS” section for additional details regarding the RIC and Therapeutics?

Clickable Links

Collin College Outpatient Monoclonal Antibody Infusion Protocol Form
Texas COVID-19 Therapeutics Availability
Information about Regeneron Cocktail (Casirivimab and Imdevimab)